[
    [
        {
            "time": "",
            "original_text": "万泰生物上半年盈利1亿半来自技术转让 销售费用率28%超A股同行",
            "features": {
                "keywords": [
                    "万泰生物",
                    "上半年",
                    "盈利",
                    "技术转让",
                    "销售费用率",
                    "A股同行"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative",
                "profit_component": "technology_transfer",
                "expense_ratio": "high_vs_peers"
            },
            "scores": {
                "News_content": "万泰生物上半年盈利1亿半来自技术转让 销售费用率28%超A股同行",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]